- Home
- VOR vs PHX Comparison
VOR vs PHX Comparison
Compare VOR & PHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VOR
- PHX
- Stock Information
- Founded
- VOR 2015
- PHX 1926
- Country
- VOR United States
- PHX United States
- Employees
- VOR N/A
- PHX N/A
- Industry
- VOR Biotechnology: Pharmaceutical Preparations
- PHX Oil & Gas Production
- Sector
- VOR Health Care
- PHX Energy
- Exchange
- VOR Nasdaq
- PHX Nasdaq
- Market Cap
- VOR 85.7M
- PHX 150.9M
- IPO Year
- VOR 2021
- PHX N/A
- Fundamental
- Price
- VOR $0.16
- PHX $3.58
- Analyst Decision
- VOR Strong Buy
- PHX
- Analyst Count
- VOR 7
- PHX 0
- Target Price
- VOR $9.43
- PHX N/A
- AVG Volume (30 Days)
- VOR 943.4K
- PHX 62.7K
- Earning Date
- VOR 05-16-2025
- PHX 05-08-2025
- Dividend Yield
- VOR N/A
- PHX 4.47%
- EPS Growth
- VOR N/A
- PHX N/A
- EPS
- VOR N/A
- PHX 0.06
- Revenue
- VOR N/A
- PHX $32,568,151.00
- Revenue This Year
- VOR N/A
- PHX $30.25
- Revenue Next Year
- VOR N/A
- PHX $4.76
- P/E Ratio
- VOR N/A
- PHX $59.50
- Revenue Growth
- VOR N/A
- PHX N/A
- 52 Week Low
- VOR $0.15
- PHX $3.09
- 52 Week High
- VOR $1.87
- PHX $4.24
- Technical
- Relative Strength Index (RSI)
- VOR 14.74
- PHX 39.99
- Support Level
- VOR $0.65
- PHX $3.53
- Resistance Level
- VOR $0.85
- PHX $3.97
- Average True Range (ATR)
- VOR 0.07
- PHX 0.13
- MACD
- VOR -0.03
- PHX -0.03
- Stochastic Oscillator
- VOR 1.88
- PHX 11.11
About VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About PHX PHX Minerals Inc.
PHX Minerals Inc is an oil and natural gas mineral company that has employed a plan to shift the core of its business away from drilling and toward perpetual mineral and natural gas ownership. The company owns substantial mineral acreage, principally in Oklahoma, North Dakota, Texas, New Mexico, and Arkansas, but still maintains legacy interests in natural gas and oil properties that have retired operations. The revenues is derived from royalties granted from the production and sale of natural gas, oil and NGL, and the remaining portion of its revenues is derived from the production and sale of natural gas, oil and NGL on its working interests.